
XMD-17-51 Trifluoroacetate NEW
Price | $68 | $163 | $263 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-25 |
Product Details
Product Name: XMD-17-51 Trifluoroacetate | CAS No.: 2436579-93-8 |
Purity: 99.65% | Supply Ability: 10g |
Release date: 2025/07/25 |
Product Introduction
Bioactivity
Name | XMD-17-51 Trifluoroacetate |
Description | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that regulates protein kinases. |
In vitro | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound proficient in modulating an extensive range of protein kinases, such as MPS1 (TTK), ERK5 (BMK1, MAPK7), various polo kinases, Ack1, Ack2, Abl and its mutants, DCAMKL1, ABL1, DCAMKL2, and many others including Bcr-Abl, GAK, cSrc, and Trk family proteins. This versatility renders it applicable in treating a diverse array of diseases, disorders, or conditions [1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Solubility Information | Ethanol : 8 mg/mL (15.43 mM), Sonication is recommended. H2O : 2 mg/mL (3.86 mM), Sonication is recommended. DMSO : 80 mg/mL (154.29 mM), Sonication is recommended. |
Keywords | XMD-17-51 Trifluoroacetate | XMD1751 Trifluoroacetate | XMD 17 51 Trifluoroacetate | NUAK1 | 1628614-50-5 free base | 1628614-50-5 |
Inhibitors Related | Doxorubicin hydrochloride | Phenformin hydrochloride | AMPK activator 12 | RGX-202 | Adenosine monophosphate | Adenosine 5'-monophosphate monohydrate | Metformin | Methyl cinnamate | Metformin hydrochloride | Chitosan oligosaccharide | Buformin hydrochloride | HTH-01-015 |
Related Compound Libraries | Anti-Colorectal Cancer Compound Library | PI3K-AKT-mTOR Compound Library | Bioactive Compound Library | HIF-1 Signaling Pathway Compound Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Anti-Ovarian Cancer Compound Library | Autophagy Compound Library | Inhibitor Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$1520.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2024-07-12 | |
$1.00/1g |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2024-03-26 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY